Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL27823886 | 1.00 | — | — | |
| Lactic Acid SCHEMBL28680492 | 1.00 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL28411516 | 1.00 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL15106432 | 1.00 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL31065863 | 1.00 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL28659699 | 1.00 | TP53 (0.85) | — | |
| Lactic Acid SCHEMBL28525023 | 1.00 | — | — | |
| Lactic Acid SCHEMBL11186009 | 0.96 | TP53 (0.79) | — | |
| Lactic Acid SCHEMBL11186000 | 0.96 | TP53 (0.79) | — | |
| Lactic Acid SCHEMBL22345879 | 0.96 | TP53 (0.79) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113735161-A | Preparation method of perovskite phase PbTiO3 ferroelectric nano material | 湖北中烟工业有限责任公司 | 2021-12-03 | — | — | CN | claimed |
| CN-117165279-A | Structural color material capable of changing color along with characteristics of light source and preparation method thereof | 中山大学 | 2023-12-05 | — | — | CN | disclosed |
| US-11351095-B2 | Stabilized emulsions with acidic agents | AVON PRODUCTS, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| EP-3681460-B1 | STABILIZED EMULSIONS WITH ACIDIC AGENTS | AVON PROD INC (US) | 2022-01-05 | — | — | EP | disclosed |
| CN-113735161-A | Preparation method of perovskite phase PbTiO3 ferroelectric nano material | 湖北中烟工业有限责任公司 | 2021-12-03 | — | — | CN | disclosed |
| CN-113735161-A | Preparation method of perovskite phase PbTiO3 ferroelectric nano material | 湖北中烟工业有限责任公司 | 2021-12-03 | — | — | CN | disclosed |
| EP-3681460-A1 | STABILIZED EMULSIONS WITH ACIDIC AGENTS | Avon Products, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| CN-108929376-A | A kind of washing methods of insulin crystal or insulin analog crystal | 鲁南制药集团股份有限公司 | 2018-12-04 | — | — | CN | disclosed |
| CN-105163847-B | Multivalence photocatalysis heterogeneous material for semiconductor | 日东电工株式会社 | 2018-04-03 | — | — | CN | disclosed |
| CN-107427815-A | Multivalence semiconductor light-catalyst material | 日东电工株式会社 | 2017-12-01 | — | — | CN | disclosed |
| CN-105163847-A | Multivalence photocatalytic heterogeneous materials for semiconductors | NITTO DENKO CORP | 2015-12-16 | — | — | CN | disclosed |
| US-20050042268-A1 | Pharmaceutical composition and method for transdermal drug delivery | PERRIGO ISRAEL PHARMACEUTICALS LTD. (IL) | 2005-02-24 | — | — | US | disclosed |